88 related articles for article (PubMed ID: 23454724)
1. Colorectal cancer in a 9-year-old due to combined EPCAM and MSH2 germline mutations: case report of a unique genotype and immunophenotype.
Li-Chang HH; Driman DK; Levin H; Siu VM; Scanlan NL; Buckley K; Cairney AE; Ainsworth PJ
J Clin Pathol; 2013 Jul; 66(7):631-3. PubMed ID: 23454724
[No Abstract] [Full Text] [Related]
2. Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5' part of MSH2.
Pérez-Cabornero L; Infante Sanz M; Velasco Sampedro E; Lastra Aras E; Acedo Becares A; Miner Pino C; Durán Domínguez M
Cancer Prev Res (Phila); 2011 Oct; 4(10):1556-62. PubMed ID: 21791569
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification.
Musulen E; Blanco I; Carrato C; Fernandez-Figueras MT; Pineda M; Capella G; Ariza A
Hum Pathol; 2013 Mar; 44(3):412-6. PubMed ID: 23026194
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Japanese Lynch syndrome patient with large deletion in the 3' region of the EPCAM gene.
Eguchi H; Kumamoto K; Suzuki O; Kohda M; Tada Y; Okazaki Y; Ishida H
Jpn J Clin Oncol; 2016 Feb; 46(2):178-84. PubMed ID: 26613680
[TBL] [Abstract][Full Text] [Related]
5. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.
Niessen RC; Hofstra RM; Westers H; Ligtenberg MJ; Kooi K; Jager PO; de Groote ML; Dijkhuizen T; Olderode-Berends MJ; Hollema H; Kleibeuker JH; Sijmons RH
Genes Chromosomes Cancer; 2009 Aug; 48(8):737-44. PubMed ID: 19455606
[TBL] [Abstract][Full Text] [Related]
6. EPCAM deletions, Lynch syndrome, and cancer risk.
Lynch HT; Lynch JF; Snyder CL; Riegert-Johnson D
Lancet Oncol; 2011 Jan; 12(1):5-6. PubMed ID: 21195320
[No Abstract] [Full Text] [Related]
7. EPCAM germline and somatic rearrangements in Lynch syndrome: identification of a novel 3'EPCAM deletion.
Spaepen M; Neven E; Sagaert X; De Hertogh G; Beert E; Wimmer K; Matthijs G; Legius E; Brems H
Genes Chromosomes Cancer; 2013 Sep; 52(9):845-54. PubMed ID: 23801599
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors.
Huth C; Kloor M; Voigt AY; Bozukova G; Evers C; Gaspar H; Tariverdian M; Schirmacher P; von Knebel Doeberitz M; Bläker H
Mod Pathol; 2012 Jun; 25(6):911-6. PubMed ID: 22388758
[TBL] [Abstract][Full Text] [Related]
9. Analysis of EPCAM protein expression in diagnostics of Lynch syndrome.
Kloor M; Voigt AY; Schackert HK; Schirmacher P; von Knebel Doeberitz M; Bläker H
J Clin Oncol; 2011 Jan; 29(2):223-7. PubMed ID: 21115857
[TBL] [Abstract][Full Text] [Related]
10. A novel missense MSH2 gene mutation in a patient of a Korean family with hereditary nonpolyposis colorectal cancer.
Park SJ; Lee KA; Park TS; Kim NK; Song J; Kim BY; Choi JR
Cancer Genet Cytogenet; 2008 Apr; 182(2):136-9. PubMed ID: 18406877
[TBL] [Abstract][Full Text] [Related]
11. Extracolonic tumours in a pedigree with EPCAM-related Lynch Syndrome.
Alves da Silva J; Castedo S; Pedroto I; Marcos-Pinto R
Eur J Med Genet; 2022 May; 65(5):104479. PubMed ID: 35367635
[TBL] [Abstract][Full Text] [Related]
12. Identification of a founder EPCAM deletion in Spanish Lynch syndrome families.
Mur P; Pineda M; Romero A; Del Valle J; Borràs E; Canal A; Navarro M; Brunet J; Rueda D; Ramón Y Cajal T; Lázaro C; Caldés T; Blanco I; Soto JL; Capellá G
Clin Genet; 2014 Mar; 85(3):260-6. PubMed ID: 23530899
[TBL] [Abstract][Full Text] [Related]
13. Recurrence and variability of germline EPCAM deletions in Lynch syndrome.
Kuiper RP; Vissers LE; Venkatachalam R; Bodmer D; Hoenselaar E; Goossens M; Haufe A; Kamping E; Niessen RC; Hogervorst FB; Gille JJ; Redeker B; Tops CM; van Gijn ME; van den Ouweland AM; Rahner N; Steinke V; Kahl P; Holinski-Feder E; Morak M; Kloor M; Stemmler S; Betz B; Hutter P; Bunyan DJ; Syngal S; Culver JO; Graham T; Chan TL; Nagtegaal ID; van Krieken JH; Schackert HK; Hoogerbrugge N; van Kessel AG; Ligtenberg MJ
Hum Mutat; 2011 Apr; 32(4):407-14. PubMed ID: 21309036
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
[TBL] [Abstract][Full Text] [Related]
15. EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients.
Ligtenberg MJ; Kuiper RP; Geurts van Kessel A; Hoogerbrugge N
Fam Cancer; 2013 Jun; 12(2):169-74. PubMed ID: 23264089
[TBL] [Abstract][Full Text] [Related]
16. Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.
Kovacs ME; Papp J; Szentirmay Z; Otto S; Olah E
Hum Mutat; 2009 Feb; 30(2):197-203. PubMed ID: 19177550
[TBL] [Abstract][Full Text] [Related]
17. Alu in Lynch syndrome: a danger SINE?
Hitchins MP; Burn J
Cancer Prev Res (Phila); 2011 Oct; 4(10):1527-30. PubMed ID: 21972078
[TBL] [Abstract][Full Text] [Related]
18. Non-Hodgkin lymphoma related to hereditary nonpolyposis colorectal cancer in a patient with a novel heterozygous complex deletion in the MSH2 gene.
Pineda M; Castellsagué E; Musulén E; Llort G; Frebourg T; Baert-Desurmont S; González S; Capellá G; Blanco I
Genes Chromosomes Cancer; 2008 Apr; 47(4):326-32. PubMed ID: 18181177
[TBL] [Abstract][Full Text] [Related]
19. Case records of the Massachusetts General Hospital. Case 13-2007. A 46-year-old woman with gynecologic and intestinal cancers.
Seiden MV; Patel D; O'Neill MJ; Oliva E
N Engl J Med; 2007 Apr; 356(17):1760-9. PubMed ID: 17460231
[No Abstract] [Full Text] [Related]
20. Pathogenicity of A600V variant in exon 12 of the MSH2 gene detected in a Japanese kindred with Lynch syndrome.
Miyakura Y; Sugano K; Nomizu T; Lefor A; Yasuda Y
Jpn J Clin Oncol; 2012 Jan; 42(1):78-82. PubMed ID: 22086974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]